Navigation Links
DIA Innovation Forum to Highlight Latest Initiatives in Research & Development in the EU
Date:8/12/2008

The Drug Information Association (DIA) will host the first http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16917&eventType=Meeting [Innovation Forum] (29-30 September; London, UK).

Basel, Switzerland (PRWEB) August 12, 2008 -- The Drug Information Association (DIA) will host the first http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16917&eventType=Meeting [Innovation Forum] (29-30 September; London, UK). This brand new conference will feature experts from the European Medicines Agency (EMEA), the Committee for Medicinal Products for Human Use (CHMP), the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Commission, European Biopharmaceutical Enterprises (EBE), EuropaBio, Eucomed and senior industry representatives.

Session topics will include:

  • Innovation in Europe - Future Challenges
  • Innovative Medicines Initiative
  • Qualification of Biomarkers and Novel Methodologies
  • Role of EMEA in Relation to Innovation
  • EU Commission and EMEA Implementation
  • EU Commission and EMEA Implementing Technical Requirements
  • Risk Management, Pharmacovigilance and Traceability
  • GMP and GCP Issues

Participants will be briefed on the latest initiatives in Europe to support innovation in research and development and will be able to share the FDA experience with the implementation of the Critical Path Initiative and coordination with the EU initiatives. The conference will provide a platform to discuss the implementation of the European Parliament and Council Regulation on Advanced Therapy and the EMEA draft technical guidelines.

About the http://www.diahome.org/ [Drug Information Association (DIA)]
The Drug Information Association serves more than 30,000 professionals in the biotechnology and pharmaceutical industries, regulatory agencies, contract research and patient organisations worldwide. Through its domestic and international meetings, training courses, workshops and webinars, the DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
+1 215-293-5812
Joe.Krasowski @ diahome.org

# # #

Read the full story at http://www.prweb.com/releases/DIA/Innovation_Forum/prweb1200974.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Sonic Innovations Appoints New President and COO
2. Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
3. Direct Technology Innovations Lauds MedeFile Solution as Breakthrough in Personal Medical Records Management
4. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
5. Spanish Health Service Provider Selects Autonomy to Deliver Innovation Within Healthcare
6. The Center for Professional Innovation and Education (CfPIE) Announces the First True Certification Program for Document Management Professionals in the Life Sciences
7. The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track
8. The Peer Group Launches Xpert Xchange(SM), an Innovation in Medical Peer Influence Programs
9. Sonic Innovations Establishes Donation Fund for the Armed Forces Foundation
10. Contract Research Development Debuts at MD&M Touting Expertise, Innovation and Collaboration
11. Microsoft Announces Winners of the 2008 Pharmaceutical and Life Sciences Innovation Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, ... published a new eBook titled “ 5 Questions to Ask Before Entering the ... on the Genetic Test Evaluation (GTE) team, the book explores the various types ...
(Date:6/20/2017)... ... June 20, 2017 , ... HOUSTON – Brazos Towers at Bayou ... host of new options for today’s modern senior. Brazos Towers at Bayou Manor has ... they love while offering them the services to support that lifestyle both now and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... in Cincinnati, OH for leading-edge care, whether or not they have a referral. ... the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without affecting ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... June 20, 2017 , ... Total Security Integrated Systems, one ... the partner of choice by Amtrak to fulfill several projects in various Northeast ... long-distance intercity service in the contiguous United States. Security Executives at the company ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... Israel , May 30, 2017 Therapix ... pharmaceutical Company specializing in the development of cannabinoid-based ... present a company overview at three upcoming scientific ... 7th Annual LD Micro Invitational: ... Date:                     ...
(Date:5/26/2017)... SANTA BARBARA, Calif. , May 25, 2017 /PRNewswire-USNewswire/ ... the United States , Direct Relief is working ... of overdose-reversing Naloxone available at no cost to community ... and other nonprofit providers nationwide. "Pfizer ... expanding access to medicines and ensuring patient safety through ...
(Date:5/22/2017)... COTTAGE, N.Y. , May 22, 2017 /PRNewswire/ ... antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of a ... plain English, the results of a clinical study ... one year treatment with Gene-Eden-VIR/Novirin in individuals suffering ... important to note that there are no other ...
Breaking Medicine Technology: